Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
39
datasets available to search
ShareScore release 0.7.1
Dataset results
39 results for “HIV Diagnosis”
INTEGRATIVE MULTI-OMICS REVEAL A TWO-ANALYTE BLOOD-BASED SIGNATURE FOR TB DIAGNOSIS IN ADVANCED HIV
GEO Series GSE166557. Homo sapiens. 56 samples. Type: Non-coding RNA profiling by high throughput sequencing.
A two-gene signature for diagnosis of tuberculosis in persons with advanced HIV
GEO Series GSE162164. Homo sapiens. 25 samples. Type: Expression profiling by high throughput sequencing.
Data from: The majority of the pre-antiretroviral population who were lost to follow-up stopped their care in Freetown, Sierra Leone: a 12-month prospective cohort study starting with HIV diagnosis
Background: The heterogeneity of the pre-antiretroviral (pre-ART) population calls for more granular depictions of the cascade of HIV care. Methods: We studied a prospective cohort of persons newly diagnosed with HIV infection from a single center in Freetown, Sierra Leone, over a 12-month period and then traced those persons who were lost to follow-up (LTFU) during pre-ART care (before ART initiation). ART eligibility was based on a CD4 cell count result of < 350 mm/cells and/or WHO clinical stage 3 or 4. Persons who attended an appointment in the final three months were considered to be retained in care. Adherence to ART was measured using pharmacy refill dates. "Effective HIV care" was defined as completion of the cascade of care at 12-months regardless of whether patients are on ART. Tracing outcomes were obtained for those who were LTFU during pre-ART care. Results: 408 persons newly diagnosed with HIV infection were screened, 338 were enrolled, and 255 persons were staged for ART. ART-ineligible persons had higher retention rates than ART-eligible persons (59.6% vs 41.8%, p=0.03). 77 (22.8%) of 338 persons received effective HIV care. Most attrition (61.9%) occurred with persons during pre-ART care. 123 of 138 persons (89.1%) who were LTFU prior to ART initiation were found, and 91 of those 123 (74.0%) were alive. Of the 74 persons who were alive and described their engagement in care, 40 (54.1%) stopped care. Nearly half (42.5%) of those 40 stopped after assessment of ART-eligibility but before ART initiation. The main limitation of this study was the lack of tracing outcomes for those lost during ART care. Conclusions: The majority of the pre-ART LTFU population stopped their care, particularly after ART-eligibility but before ART initiation. Interventions to hasten ART initiation and retain this at-risk group may have significant downstream impact on effective HIV care.
SMF to Improve Performance of Microscopy for the Diagnosis of PTB in a High HIV Prevalence Setting
ClinicalTrials.gov study NCT02701439. IPD Sharing: NO. Countries: 1. Publications: 0.
Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children
ClinicalTrials.gov study NCT03984552. IPD Sharing: NO. Countries: 1. Publications: 0.
Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E
ClinicalTrials.gov study NCT03988725. IPD Sharing: NO. Countries: 1. Publications: 0.
Prevention of Missed Opportunities for HIV Diagnosis by Promoting HIV Testing of Patients With Pneumococcal Pneumonia at Nice University Hospital (PneumoVIH)
ClinicalTrials.gov study NCT04909268. IPD Sharing: NO. Countries: 1. Publications: 0.
Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests
ClinicalTrials.gov study NCT04880200. IPD Sharing: YES. Countries: 1. Publications: 0.
Readiness to Disclose Mother's HIV Diagnosis to Their Children in Beijing, China
ClinicalTrials.gov study NCT03248778. IPD Sharing: NO. Countries: 1. Publications: 0.
Diagnosis of Tuberculosis Infection in HIV Co-infected Children
ClinicalTrials.gov study NCT00541294. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pneumocystis Pneumonia Diagnosis in HIV- Patients
ClinicalTrials.gov study NCT02648256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
ClinicalTrials.gov study NCT03642704. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
ClinicalTrials.gov study NCT00647205. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Integrated Care (iCare) at Mount Sinai to Improve Substance Use Diagnosis and Treatment Practices in HIV Clinic Settings
ClinicalTrials.gov study NCT03092596. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dyadic-Based Diagnosis, Care, and Prevention for HIV Discordant Couples in Tanzania
ClinicalTrials.gov study NCT03098693. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect on the HIV Diagnosis Rates of Integration of AIDS Indicator Conditions Into the Hospital Information Systems
ClinicalTrials.gov study NCT05666882. IPD Sharing: NO. Countries: 1. Publications: 0.
Data from: The majority of the pre-antiretroviral population who were lost to follow-up stopped their care in Freetown, Sierra Leone: a 12-month prospective cohort study starting with HIV diagnosis
Open the record for dataset details and reuse information.
Lipoarabinomannan (LAM) in Urine for Diagnosis of Pulmonary Tuberculosis in HIV Patients
ClinicalTrials.gov study NCT04813666. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis
ClinicalTrials.gov study NCT07146529. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.